Psychedelic Science 2025: Lessons From MDMA Trials Could Strengthen Future Psychedelic Approvals
July 28th 2025Joel Stanley of Ajna Biosciences reflects on the regulatory challenges surrounding MDMA-assisted therapy, outlines lessons for future psychedelic drug trials, and emphasizes the importance of scientific rigor, interdisciplinary infrastructure, and the evolving role of pharmacists in ensuring safe clinical integration.
Read More